Kombinationen mit Psychopharmaka in der Behandlung von Angst- und Zwangsstörungen
Publisher
Springer Vienna
Reference163 articles.
1. Aboujaoude E, Barry JJ, Gamel N (2009) Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. J Clin Psychopharmacol 29: 51–55
2. Agid O, Lerer B (1999) Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. J Clin Psychiaty 60: 55–56
3. Ahearn EP, Mussey M, Johnson C, Krohn A, Krahn D (2006) Quetiapine as an adjucntive treatment for post-traumatic stress disorder: an 8-week open-label study. Int Clin Psychopharmacol 21: 29–33
4. Ak M, Bulut SD, Bozkurt A, Ozsahin A (2011) Aripiprazol augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study. Adv Ther 28: 341–348
5. Altamura AC, Serati M, Buoli M, Dell`Osso B (2011) Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder: a randomized, placebo-controlled study. Int Clin Psychopharmacol 26: 201–205